Form 4 for BMY Bristol Myers Squibb
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0000014272-22-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | +23.4K | 79.6K | +42% | $0 |
| D | 2022-03-03 | 2022-03-01 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | F - Tax | $68.63 | -10.3K | 69.3K | -13% | -$707.1K |
| D | 2022-03-03 | 2022-03-01 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | -23.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2022-03-01 | M | A | 23,350 | $0.00 | 79,587 | D | — | — | (F1) Each restricted stock unit vested in three equal installments beginning on March 1, 2020. |
| 2 | Common | Common Stock, $0.10 par value | 2022-03-01 | F | D | 10,303 | $68.63 | 69,284 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of restricted stock unit awards. |
| 3 | Derivative | Restricted Stock Units | 2022-03-01 | M | D | 23,350 | $0.00 | 0 | D | — · — to 2022-03-01 | 23,350 Common Stock, $0.10 par value | (F1) Each restricted stock unit vested in three equal installments beginning on March 1, 2020. (F4) Each restricted stock unit converts into one share of common stock upon vesting. |